熱門資訊> 正文

Achieve Life Sciences通过新的首席运营官加强领导团队

2025-09-18 23:46

Achieve Life Sciences (NASDAQ:ACHV) promoted Craig Donnelly to COO.
Mr. Donnelly will lead the supply chain and manufacturing activities with the commercial strategy ahead of a product launch in mid-late 2026.
With more than 25 years of biopharmaceutical industry experience, Mr. Donnelly has expertise in both technical development and regulatory CMC at all stages of development.
Mr. Donnelly previously held senior roles in CMC and regulatory functions at companies including NuCana, ICON (formerly Mapi), and F. Hoffman-La Roche.

More on Achieve Life Sciences

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript
Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation
Achieve Life Sciences gets new interim chief medical officer
Achieve Life Sciences' nicotine dependence treatment under FDA review
Seeking Alpha’s Quant Rating on Achieve Life Sciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。